Champions Oncology Inc
SWB:2I3

Watchlist Manager
Champions Oncology Inc Logo
Champions Oncology Inc
SWB:2I3
Watchlist
Price: 5.3 EUR 4.95% Market Closed
Market Cap: €113.3m

Wall St Price Targets

2I3 Price Targets Summary
Champions Oncology Inc

There are no price targets for 2I3.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Champions Oncology Inc Competitors:
Price Targets
AGCO
AGCO Corp
19% Upside

Revenue
Forecast

16% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
16% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 4 years is 22%.

Gross Profit
Forecast

20% / Year
Past Growth
-5% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
20% / Year
Past Growth
-5% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been 20%. The projected CAGR for the next 1 year is -5%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-27%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-27%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-25%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-25%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 2I3's stock price target?
Not Available

2I3 does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Champions Oncology Inc?
Projected CAGR
22%

Over the last 14 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 4 years is 22%.

What is the Gross Profit forecast for Champions Oncology Inc?
Projected CAGR
-5%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 20%. The projected CAGR for the next 1 year is -5%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett